← FDA Drug Approvals (Drugs@FDA)

KANJINTI

BLA · Biologics License Application · Sponsor: AMGEN INC · Approved 2019-06-13

Drug application

FDA Application #

BLA761073

Application type

Biologics License Application

Brand name

KANJINTI

Generic name

TRASTUZUMAB-ANNS

Active ingredients

TRASTUZUMAB-ANNS

Dosage form

VIAL

Route

SINGLE-DOSE

Marketing status

Prescription

Sponsor

AMGEN INC

Manufacturer

Amgen, Inc

First approval

2019-06-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown